Conversion to lacosamide monotherapy in the treatment of focal epilepsy: results from a historical-controlled, multicenter, double-blind study
about
Lacosamide in status epilepticus: Systematic review of current evidence.Efficacy and safety of conversion to monotherapy with eslicarbazepine acetate in adults with uncontrolled partial-onset seizures: a historical-control phase III study.Conversion to eslicarbazepine acetate monotherapy: A pooled analysis of 2 phase III studiesEfficacy and safety of conversion to monotherapy with eslicarbazepine acetate in adults with uncontrolled partial-onset seizures: a randomized historical-control phase III study based in North AmericaNew developments in the management of partial-onset epilepsy: role of brivaracetam.The efficacy of lacosamide as monotherapy and adjunctive therapy in focal epilepsy and its use in status epilepticus: clinical trial evidence and experienceTime-to-Seizure Modeling of Lacosamide Used in Monotherapy in Patients with Newly Diagnosed Epilepsy.Practical Use of Newer Antiepileptic Drugs as Adjunctive Therapy in Focal Epilepsy.Lacosamide: A Review in Focal Seizures in Patients with Epilepsy.Methodological issues associated with clinical trials in epilepsy.Sodium Channel Blockers in the Treatment of Epilepsy.Third generation antiepileptic drug monotherapies in adults with epilepsy.Tolerability and Safety of Commonly Used Antiepileptic Drugs in Adolescents and Adults: A Clinician's Overview.Early add-on lacosamide in a real-life setting: results of the REALLY study.Status epilepticus developing during lacosamide monotherapy.Influence of adjunctive lacosamide in patients with seizures: a systematic review and meta-analysis.Pharmacokinetic drug evaluation of lacosamide for the treatment of partial-onset seizures.
P2860
Q30399934-D80EBFE9-5112-4798-935A-9B0F97EA3F3BQ35424907-1613F265-E17A-403E-A832-3C506118B0CFQ36782895-07F3079F-4133-49D3-B568-E872F2BACFD2Q37243357-9E515394-2243-4656-B44C-482CF3C7DFFCQ37693757-4CB2174E-8A1B-4457-BA0C-F07F19A1B49AQ37722778-49D2B7BA-8923-40CD-8372-CC03521949F1Q38379471-A2E8B2C8-38DC-40F7-80C3-908E54592371Q38617833-FD9DC8F2-2936-4647-A8EC-15D06907CF2EQ38647788-207A82D4-2FF5-4DAA-BA4B-C8E523A95992Q38656392-BEF8E7E3-7DCF-4D28-B018-7252C97AB182Q38775516-E20E79D4-18C3-40DA-9AB5-325C21CA9D3AQ38849966-16E5C98A-34D8-4AFF-B1DB-0EC5020ABE02Q39094490-62B41FA6-749D-4B59-8187-175AB3B0FD65Q41713574-9CACE5C3-B37F-4151-AE54-4F952E73B50CQ41875012-E336F505-B98C-4140-B802-1A09BB94C222Q47418044-30DDBF6B-7D5B-4230-B059-AF06B7D6EA69Q48020465-D6656AB5-E23B-4F8C-BE31-A74B229AA179
P2860
Conversion to lacosamide monotherapy in the treatment of focal epilepsy: results from a historical-controlled, multicenter, double-blind study
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Conversion to lacosamide monot ...... ulticenter, double-blind study
@ast
Conversion to lacosamide monot ...... ulticenter, double-blind study
@en
type
label
Conversion to lacosamide monot ...... ulticenter, double-blind study
@ast
Conversion to lacosamide monot ...... ulticenter, double-blind study
@en
prefLabel
Conversion to lacosamide monot ...... ulticenter, double-blind study
@ast
Conversion to lacosamide monot ...... ulticenter, double-blind study
@en
P2093
P2860
P356
P1433
P1476
Conversion to lacosamide monot ...... ulticenter, double-blind study
@en
P2093
ALEX-MT Study Group
Jacqueline French
Melissa Brock
O'Neill D'Cruz
Paulette Williams
Robert T Wechsler
Robin Goodson
P2860
P304
P356
10.1111/EPI.12681
P577
2014-06-10T00:00:00Z